TGF-β Signaling and Resistance to Cancer Therapy
The transforming growth factor β (TGF-β) pathway, which is well studied for its ability to inhibit cell proliferation in early stages of tumorigenesis while promoting epithelial-mesenchymal transition and invasion in advanced cancer, is considered to act as a double-edged sword in cancer. Multiple i...
Saved in:
Main Authors: | Maoduo Zhang, Ying Yi Zhang, Yongze Chen, Jia Wang, Qiang Wang, Hezhe Lu |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/32246b949cc74d93a2c11dfb1e2ea4b9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
by: David J. Benjamin, et al.
Published: (2021) -
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
by: Wang Jian, et al.
Published: (2020) -
The Role of TGF-β in Bone Metastases
by: Trupti Trivedi, et al.
Published: (2021) -
RNAseq of TGF-β receptor type I kinase-dependent genes in oral fibroblast exposed to milk
by: Layla Panahipour, et al.
Published: (2021) -
TGFβ1 Secreted by Cancer-Associated Fibroblasts as an Inductor of Resistance to Photodynamic Therapy in Squamous Cell Carcinoma Cells
by: María Gallego-Rentero, et al.
Published: (2021)